Pathology of Ovarian Cancers in <b> <i>BRCA1</i> </b> and <b> <i>BRCA2</i> </b> Carriers

Use of pathological features can substantially improve the targeting of predictive genetic testing. Results also suggest that BRCA1 and BRCA2 tumors are relatively aggressive and may be expected to have poor prognosis, although this may be treatment dependent.